Skip to main content

Table 2 Role of cargoes in EVs in regulating drug resistance in CRC

From: The application of extracellular vesicles in colorectal cancer metastasis and drug resistance: recent advances and trends

non-coding RNA/protein/gene

Source

Expression pattern

Action target/pathway

Outcome

References

a. Chemical resistance

 miR-208b

Tumor

Upregulated

PDCD4

OX resistance

[117]

 miR-424

Tumor

CD28-CD80/86 costimulatory pathway

Immune checkpoint blockade

[44]

 miR-46146

Tumor

Upregulated

PDCD10

OX resistance

[118]

 miR-21

Tumor

Upregulated

PDCD4, TPM1, PTEN

5-FU resistance

[119]

 miR-24-3p

CAF

Upregulated

CDX2

MTX resistance

[56]

 ciRS-122

Tumor

Upregulated

miR-122

OX resistance

[120]

 circ_0000338

Tumor

Upregulated

miR-217, miR-485-3p

5-FU resistance

[121]

 cricN4BP2L2

CAF

Upregulated

EIF4A3

OX resistance

[49]

 lncRNA HOTTIP

Tumor

Upregulated

miR-214

Mitomycin resistance

[50]

 lncRNA CCAL

CAF

Upregulated

mRNA stabilizing protein HuR

OX resistance

[48]

 p-STAT3

Tumor

Upregulated

-

5-FU resistance

[53]

 DNAJB8

Tumor

Upregulated

TP53

OX resistance

[51]

b. Chemically sensitive

 miR-1915-3p

FHC

Upregulated

PFKFB3, USP2, E-cadherin

OX sensitive

[75]

 miR-204-5p

HEK293T

Upregulated

RAB22A, Bcl2

5-FU sensitive

[122]

 circ_0094343

CAF

Downregulated

miR-766-5p

Sensitive to 5-FU, OX, and Dox

[123]

  1. PDCD4 programmed cell death factor 4, PDCD10 Programmed cell death 10, TPM1 Tropomyosin 1, PTEN Phosphatase and tensin homolog, MTX methotrexate, CDX2 caudal‐related homeobox 2, EIF4A3 Eukaryotic initiation factor 4A-III, 5-FU 5-Fluorouracil, OX Oxaliplatin, PFKFB3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3, USP2 ubiquitin carboxyl-terminal hydrolase 2, Dox doxorubicin